- Home
- LNZA vs PROF Comparison
LNZA vs PROF Comparison
Compare LNZA & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNZA
- PROF
- Stock Information
- Founded
- LNZA 2005
- PROF N/A
- Country
- LNZA United States
- PROF Canada
- Employees
- LNZA N/A
- PROF N/A
- Industry
- LNZA Major Chemicals
- PROF Medical/Dental Instruments
- Sector
- LNZA Industrials
- PROF Health Care
- Exchange
- LNZA Nasdaq
- PROF Nasdaq
- Market Cap
- LNZA 199.8M
- PROF 201.2M
- IPO Year
- LNZA N/A
- PROF N/A
- Fundamental
- Price
- LNZA $0.86
- PROF $7.48
- Analyst Decision
- LNZA Strong Buy
- PROF Strong Buy
- Analyst Count
- LNZA 3
- PROF 2
- Target Price
- LNZA $4.33
- PROF $11.40
- AVG Volume (30 Days)
- LNZA 1.8M
- PROF 100.0K
- Earning Date
- LNZA 02-26-2025
- PROF 03-06-2025
- Dividend Yield
- LNZA N/A
- PROF N/A
- EPS Growth
- LNZA N/A
- PROF N/A
- EPS
- LNZA N/A
- PROF N/A
- Revenue
- LNZA $58,025,000.00
- PROF $8,984,000.00
- Revenue This Year
- LNZA $2.13
- PROF $56.56
- Revenue Next Year
- LNZA $85.81
- PROF $151.33
- P/E Ratio
- LNZA N/A
- PROF N/A
- Revenue Growth
- LNZA 7.99
- PROF 39.35
- 52 Week Low
- LNZA $0.66
- PROF $5.63
- 52 Week High
- LNZA $3.54
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- LNZA 43.62
- PROF 65.75
- Support Level
- LNZA $0.66
- PROF $5.63
- Resistance Level
- LNZA $1.07
- PROF $6.36
- Average True Range (ATR)
- LNZA 0.12
- PROF 0.36
- MACD
- LNZA 0.03
- PROF 0.18
- Stochastic Oscillator
- LNZA 49.02
- PROF 87.26
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a nature-based carbon refining company that transforms waste carbon into the chemical building blocks for consumer goods such as sustainable fuels, fabrics, and packaging that people use in their daily lives. The company's goal is to reduce the need for virgin fossil fuels by challenging and striving to change the way the world uses carbon.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.